V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007572 | 220002988 | 1.77 | 94.6 | Curative (C) | 2017-06-02 | 2017-06-02 | Idarubicin+Tretinoin Spanish Crse4 | null | N | 220032698 | IDARUBICIN + TRETINOIN |
| 220007573 | 220002989 | 1.59 | 77.1 | Palliative (P) | 2014-04-13 | 2014-03-17 | Carboplatin + Paclitaxel (weekly) | 02 | N | 220032710 | CARBOPLATIN + PACLITAXEL |
| 220007574 | 220002990 | 1.6 | null | Palliative (P) | 2015-06-01 | 2015-06-09 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032713 | CARBOPLATIN + PACLITAXEL |
| 220007575 | 220002991 | 1.71 | 57 | Curative (C) | 2016-11-11 | 2016-11-11 | Dasatinib | N | N | 220032714 | DASATINIB |
| 220007576 | 220002992 | null | 71 | Curative (C) | 2013-05-19 | 2013-05-20 | AML 18 TRIAL | 1 | N | 220032716 | AML18 TRIAL |
| 220007577 | 220002992 | 1.69 | 67.4 | Curative (C) | 2016-11-04 | 2016-11-05 | IDARUBICIN + TRETINOIN | 02 | N | 220032716 | IDARUBICIN + TRETINOIN |
| 220007578 | 220002993 | 1.57 | 114 | Palliative (P) | 2013-11-21 | 2013-12-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220032718 | CISPLATIN + GEMCITABINE |
| 220007579 | 220011678 | 1.67 | null | Curative (C) | 2013-08-11 | 2013-08-15 | Idarubicin+Tretinoin Spanish Crse1 | Y | N | 220032721 | IDARUBICIN + TRETINOIN |
| 220007580 | 220002994 | null | 78.7 | Curative (C) | 2013-12-14 | 2013-12-14 | AML 18 TRIAL | Y | N | 220032722 | AML18 TRIAL |
| 220007581 | 220002995 | 1.74 | 76.2 | Curative (C) | null | 2016-12-14 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220032724 | IDARUBICIN + TRETINOIN |
| 220007582 | 220002996 | null | 79 | Curative (C) | 2016-10-12 | 2016-10-12 | AML16 DA 3+10 | N | N | 220032726 | AML16 TRIAL |
| 220007583 | 220002997 | 1.76 | 91.2 | Curative (C) | 2013-04-07 | 2013-04-07 | Idarubicin+Tretinoin Spanish Crse2 | null | null | 220032727 | IDARUBICIN + TRETINOIN |
| 220007584 | 220002998 | null | 61 | null | 2017-02-24 | 2017-04-06 | CISPLATIN + GEMCITABINE | 02 | null | 220032728 | CISPLATIN + GEMCITABINE |
| 220007585 | 220002999 | null | 93 | Palliative (P) | 2013-10-03 | 2013-10-09 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220032729 | CISPLATIN + GEMCITABINE |
| 220007586 | 220011679 | 1.73 | 108.7 | Palliative (P) | 2016-07-22 | 2016-07-28 | Carboplatin + Paclitaxel (weekly) | N | N | 220032730 | CARBOPLATIN + PACLITAXEL |
| 220007587 | 220011679 | 1.74 | 103 | Curative (C) | 2016-04-01 | 2016-05-02 | CARBOPLATIN + PACLITAXEL | N | null | 220032730 | CARBOPLATIN + PACLITAXEL |
| 220007588 | 220011679 | 1.76 | null | Adjuvant (A) | 2017-01-19 | 2017-01-20 | AML18 PILOT TRIAL | Y | N | 220032730 | PILOT TRIAL |
| 220007589 | 220003000 | 1.8 | 93.2 | Palliative (P) | 2015-12-17 | 2015-12-20 | Carboplatin + Paclitaxel (weekly) | 02 | N | 220032736 | CARBOPLATIN + PACLITAXEL |
| 220007590 | 220003001 | 1.55 | 68.4 | Palliative (P) | 2017-01-23 | 2017-01-24 | Dasatinib | 2 | N | 220032740 | DASATINIB |
| 220007591 | 220003001 | 1.85 | 80 | Curative (C) | 2017-02-24 | 2017-02-27 | AML18 PILOT TRIAL | Y | N | 220032740 | PILOT TRIAL |
| 220007592 | 220003001 | 1.62 | 81.4 | Curative (C) | 2013-12-21 | 2013-12-22 | AML 18 TRIAL | 01 | null | 220032740 | AML18 TRIAL |
| 220007593 | 220003001 | 1.66 | 97.1 | Palliative (P) | 2017-10-04 | 2017-10-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032740 | CISPLATIN + GEMCITABINE |
| 220007594 | 220003001 | 1.61 | 87.5 | Curative (C) | 2014-04-14 | 2014-05-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032740 | CARBOPLATIN + PACLITAXEL |
| 220007595 | 220003002 | 1.68 | 53 | Not known (9) | 2014-02-20 | 2014-02-24 | IDARUBICIN + TRETINOIN | N | N | 220032753 | IDARUBICIN + TRETINOIN |
| 220007596 | 220003002 | 1.55 | 63.4 | Curative (C) | 2014-04-08 | 2014-04-11 | AML16 DA 3+10 | N | N | 220032753 | AML16 TRIAL |
| 220007597 | 220003003 | 1.67 | 74 | Curative (C) | 2015-04-23 | 2015-04-29 | Carboplatin + Paclitaxel (weekly) | N | N | 220032756 | CARBOPLATIN + PACLITAXEL |
| 220007598 | 220003003 | 1.85 | 98 | Palliative (P) | 2014-09-18 | 2014-09-23 | CARBOPLATIN + PACLITAXEL | 02 | N | 220032756 | CARBOPLATIN + PACLITAXEL |
| 220007599 | 220003004 | 1.65 | 78 | null | 2013-02-06 | 2013-02-18 | Dasatinib | 2 | null | 220032762 | DASATINIB |
| 220007601 | 220003006 | 1.68 | 55 | Palliative (P) | null | 2014-09-01 | GemCarbo Days 1+8 | N | N | 220032770 | GEMCARBO |
| 220007602 | 220003006 | 1.8 | null | Curative (C) | 2017-01-03 | 2017-01-13 | AML16 Low Dose Cytarabine | N | N | 220032770 | AML16 TRIAL |
| 220007603 | 220016285 | 1.58 | 90.6 | Palliative (P) | 2013-06-21 | 2013-06-27 | CARBOPLATIN + PACLITAXEL | 02 | N | 220032772 | CARBOPLATIN + PACLITAXEL |
| 220007604 | 220016285 | 1.74 | 66 | null | 2015-11-27 | 2015-11-27 | Dasatinib | 02 | N | 220032772 | DASATINIB |
| 220007605 | 220016285 | 1.61 | 68.7 | Curative (C) | 2014-09-25 | 2014-09-30 | AML18 PILOT TRIAL | N | N | 220032772 | PILOT TRIAL |
| 220007606 | 220003007 | 1.74 | 54 | Curative (C) | 2016-07-25 | 2016-08-10 | Dasatinib | 2 | N | 220032779 | DASATINIB |
| 220007607 | 220003007 | 1.68 | 81 | Curative (C) | 2016-11-08 | 2016-11-08 | IDARUBICIN + TRETINOIN | null | N | 220032779 | IDARUBICIN + TRETINOIN |
| 220007608 | 220003008 | null | 85.3 | null | 2014-10-27 | 2014-11-13 | GEMCARBO | N | N | 220032781 | GEMCARBO |
| 220007609 | 220003008 | 1.75 | 57 | Disease modification (D) | 2015-06-10 | 2015-06-14 | AML16 Low Dose Cytarabine | N | N | 220032781 | AML16 TRIAL |
| 220007610 | 220003008 | 1.62 | 52 | Curative (C) | 2017-09-29 | 2017-09-29 | IDARUBICIN + TRETINOIN | Y | N | 220032781 | IDARUBICIN + TRETINOIN |
| 220007611 | 220003008 | 1.65 | 107 | Not known (9) | 2015-07-30 | 2015-07-30 | IDARUBICIN + TRETINOIN | N | N | 220032781 | IDARUBICIN + TRETINOIN |
| 220007612 | 220003008 | null | null | null | 2013-01-18 | 2013-03-04 | AML16 DA 3+10 | Y | N | 220032781 | AML16 TRIAL |
| 220007613 | 220003009 | 1.87 | 126 | Disease modification (D) | 2013-05-10 | 2013-05-10 | AML16 Azacitidine | N | N | 220032790 | AML16 TRIAL |
| 220007614 | 220003009 | 1.77 | null | Curative (C) | 2016-03-24 | 2016-03-24 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220032790 | IDARUBICIN + TRETINOIN |
| 220007615 | 220003009 | 1.75 | 89 | Palliative (P) | 2014-11-12 | 2014-11-19 | GemCarbo Days 1+8 | 02 | N | 220032790 | GEMCARBO |
| 220007616 | 220003009 | 1.56 | 45.2 | Curative (C) | null | 2015-07-22 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220032790 | IDARUBICIN + TRETINOIN |
| 220007618 | 220003010 | 1.69 | 80.7 | Curative (C) | 2014-11-23 | 2014-10-27 | CARBOPLATIN + PACLITAXEL | null | N | 220032798 | CARBOPLATIN + PACLITAXEL |
| 220007621 | 220016288 | 1.6 | 68.4 | Not known (9) | 2015-12-16 | 2015-12-17 | IDARUBICIN + TRETINOIN | 2 | N | 220032801 | IDARUBICIN + TRETINOIN |
| 220007622 | 220003012 | 1.7 | 80 | Adjuvant (A) | 2015-01-10 | 2015-02-20 | Dasatinib | 02 | null | 220032803 | DASATINIB |
| 220007623 | 220003013 | 1.73 | 67.3 | Palliative (P) | 2013-07-22 | 2013-07-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032804 | CARBOPLATIN + PACLITAXEL |
| 220007626 | 220003014 | 1.84 | 94 | null | 2016-12-05 | 2016-12-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032809 | CISPLATIN + GEMCITABINE |
| 220007627 | 220003014 | 1.55 | 79 | null | 2017-05-11 | 2017-05-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032809 | CISPLATIN + GEMCITABINE |